trending Market Intelligence /marketintelligence/en/news-insights/trending/cgmxfHrZUVnoj88ef4tErg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Rhythm Pharmaceuticals prices IPO

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Rhythm Pharmaceuticals prices IPO

Rhythm Pharmaceuticals Inc. priced its IPO of 7,050,000 common shares at $17 apiece.

The company granted underwriters a 30-day option to buy up to an additional 1,057,500 common shares at the offering price.

The shares are scheduled to start trading Oct. 5 on the Nasdaq Global Market under the symbol RYTM.

The offering is expected to close Oct. 10, subject to customary closing conditions.

Morgan Stanley, BofA Merrill Lynch and Cowen are acting as lead book-running managers of the offering, with Needham & Co. as co-manager.